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ABSTRACT 27 
Artificial gravity through short-arm centrifugation has potential as a multi-system 28 
countermeasure for deconditioning and cranial fluid shifts that may underlie ocular issues 29 
in microgravity. However, the optimal short-arm centrifugation protocol that is effective 30 
whilst remaining tolerable has yet to be determined.  31 
Given that exposure to centrifugation is associated with presyncope and syncope and in 32 
addition motion sickness an intermittent protocol has been suggested to be more 33 
tolerable. Therefore, we assessed cardiovascular loading and subjective tolerability of 34 
daily short arm centrifugation with either an intermittent or a continuous protocol during 35 
long-term head-down bed rest as model for microgravity exposure in a mixed sex cohort.    36 
During the Artificial Gravity Bed Rest with European Space Agency (AGBRESA) 60 day 37 
6° head down tilt bed rest study we compared the tolerability of daily +1 Gz exposure at 38 
the center of mass centrifugation, either performed continuously for 30 minutes, or 39 
intermittedly (6 x 5 minutes).  Heart rate and blood pressure were assessed daily during 40 
centrifugation along with post motion sickness scoring and rate of perceived exertion. 41 
During bed rest, 16 subjects (6 women, 10 men), underwent 960 centrifuge runs in total. 42 
Ten centrifuge runs had to be terminated prematurely, 8 continuous runs and 2 43 
intermittent runs, mostly due to pre-syncopal symptoms and not motion sickness. All 44 
subjects were, however, able to resume centrifuge training on subsequent days.  45 
We conclude that both continuous and intermittent short-arm centrifugation protocols 46 
providing artificial gravity equivalent to +1 Gz at the center of mass is tolerable in terms of 47 
cardiovascular loading and motion sickness during long-term head down tilt bed rest. 48 
However, intermittent centrifugation appears marginally better tolerated, albeit differences 49 
appear minor. 50 
 51 
 52 
INTRODUCTION 53 
Long term space missions elicit multi-system deconditioning including reduced skeletal 54 
muscle strength [1], bone mineral density [2], and central blood volume [3-5]. Moreover, 55 
sustained cephalad fluid shifts appear to negatively affect ocular health and brain 56 
structure, leading to the so-called space associated neuro-ocular syndrome [6, 7]. 57 
Furthermore, returning astronauts may experience reduced aerobic capacity [8], and 58 
pre-syncopal symptoms indicative of poorer orthostatic tolerance [9]. In an attempt to 59 
counter deconditioning on the International Space Station, integrated resistance and 60 
aerobic training is prescribed using a number of dedicated devices [10].  61 
Crewmembers train 6-7 days per week with 6-7 resistance and 4-7 cardiovascular 62 
sessions per week [11, 12]. Daily training requires approximately 2.5 hours per 63 
crewmember including the training, rest periods, and equipment setup, stowage and 64 
cleaning. Despite the substantial investment of time, resource and effort this approach is 65 
not entirely effective in mitigating musculoskeletal [13], nor aerobic [5, 14] 66 
deconditioning, hence physical rehabilitation is required following return to Earth. 67 
Moreover, no effective countermeasures against space associated neuro-ocular 68 
syndrome currently exist. Thus more effective and ideally more efficient 69 
countermeasures are required for future missions to the Moon, and beyond [15]. 70 
Artificial gravity through axial acceleration generated by short-arm human 71 
provides musculoskeletal loading via the generation of ground reaction forces and an 72 
orthostatic challenge through a hydrostatic pressure gradient both of which are absent in 73 
microgravity.  Indeed, short-arm human centrifugation may attenuate bone, muscle, and 74 
cardiovascular deconditioning [16] induced by 6° head-down bed rest. For instance, in 75 
short term (5 day) bed rest, an established terrestrial model of cephalad fluid shifts and 76 
space-associated deconditioning [17]) studies, daily 30 minutes centrifugation with at 77 
least 1 g at the center of mass resulted in no change in postural muscle strength with 78 
good tolerability [18, 19]. Furthermore, exposure to artificial gravity appeared to provide 79 
protection against post-bed rest orthostatic intolerance [20-22]. The primary objective of 80 
the AGBRESA bed rest study is to compare the protective effects of one single daily 81 
bout (30 min) versus multiple daily bouts of AG (6 x 5 min) on physiological functions 82 
that are affected by simulated weightlessness during 60 days of bed rest.  83 
However, exposure to exaggerated hydrostatic pressure gravitational gradients 84 
induced by centrifugation can elicit presyncopal symptoms or syncope [20, 23, 24]. 85 
Furthermore, head movements within a rotating environment are associated with motion 86 
sickness symptoms [25]. Yet, to be acceptable as an integrative spaceflight 87 
countermeasure, a form of repeated exposure to artificial gravity needs to be tolerable 88 
over a long duration mission for both males and females as a number of recent studies 89 
have observed sex differences in autonomic cardiovascular control during exposure to 90 
orthostatic stress [23, 26, 27]. 91 
Thus, the aim of our study were to assess the tolerability of daily 30 minute 92 
intermittent, or continuous short-arm centrifugation with 1 g at center of mass during 60 93 
days (6o) head-down bedrest in a mixed sex cohort.  94 
 95 
METHODS 96 
Study subjects. This study is part of the NASA/ESA/DLR 60-day 6o head down 97 
bed rest study ‘Artificial Gravity Bed Rest with European Space Agency’ (AGBRESA) 98 
that was conducted from March until December 2019 at the :envihab facility of the 99 
Institute of Aerospace Medicine of the German Aerospace Center (DLR) in Cologne, 100 
Germany. The study enrolled 24 healthy individuals (16 men, 8 women), who had been 101 
submitted to detailed medical and psychological screening having provided written 102 
informed consent. The study was approved by the North Rhine Medical Association 103 
(2018143 vote from 17.08.2018).  104 
Protocol. Following a 14-day baseline data collection period, study subjects 105 
entered 60 days of strict 6° head-down bed rest. At the end of the baseline data collection 106 
phase, participants were pseudo-randomly distributed into 3 groups: a control group with 107 
no centrifugation, an intermittent centrifugation group, and a continuous centrifugation 108 
group. The intermittent centrifugation group underwent daily 6x5 minutes centrifugation 109 
with 3 minutes breaks between runs (Figure 1: Left Panel). The continuous centrifugation 110 
group underwent a single daily 30 minute centrifugation run (Figure 1: Right Panel).  111 
All centrifugation was performed using the :envihab short-arm human centrifuge 112 
with participants exposed to +1 Gz at their center of mass (CoM) and thus approximately 113 
+2 Gz at foot level. Rotational speed of the centrifuge was calculated individually based 114 
upon each subject’s anthropometry to determine center of mass (ratio center of mass to 115 
body height 56% for male/ 54% for female). During ramp up/down phases, 116 
(de)acceleration did not exceed 5° s-2 to reduce the risk of vestibular-induced tumbling 117 
sensations.All subjects underwent two centrifuge familiarization sessions prior to bed rest 118 
at the same +Gz level as the main study with an intermittent profile of two 5 minute 119 
periods separated by a 3 minute break.  120 
Head restrainers were not provided, but participants were instructed to keep their 121 
body and head still throughout the centrifugation as much as possible. To assist in 122 
maintaining consciousness and limit pre-syncopal symptoms, subjects were trained, prior 123 
to the bed rest campaign, in the performance of voluntary isometric calf muscle pump 124 
contractions along with (the trunk and gluteal muscles) to promote venous return [28]. 125 
However, subjects were instructed to contract only when experiencing significant (pre-126 
syncopal) symptoms such as dizziness or blurred vision.  127 
Cardiovascular monitoring. During centrifugation, heart rate was continuously 128 
recorded via a five lead electrocardiogram in addition to periodic brachial blood pressure 129 
(Philips IntelliVue® MP2). In the intermittent centrifugation group, blood pressure was 130 
recorded 2 minutes after each plateau (+1 Gz at center of mass), and in the continuous 131 
centrifugation group 2 minutes after the plateau was achieved and every 5 minutes 132 
thereafter. Mean heart rate, systolic and diastolic blood pressure were calculated for each 133 
first measurement intervals during centrifugation on bed rest days 1, 30 and 60 and 134 
compared between intervention groups.  135 
Documentation of all adverse events including premature stops, pre-syncopal signs 136 
or cardiac dysrhythmias was performed to facilitate evaluation of tolerability.  137 
 Subjective tolerability assessment. General motion sickness susceptibility 138 
questionnaire short-form (MSSQ-SF) [29] was determined prior to the head down tilt bed 139 
rest including both childhood (MSA) and adulthood (MSB) sub-scores. In both centrifuge 140 
groups, Subjective Motion Sickness Ratings (MS: 0 “I am feeling fine” to 20 “I am about to 141 
vomit” )[30] and rate of perceived exertion (RPE: 6 “No exertion at all” to 20 “Maximal 142 
exertion”) [31] directly after every centrifuge run during bed rest were recorded. 143 
Furthermore, Motion Sickness Assessment Questionnaire (MSAQ), Positive and Negative 144 
Affect Schedule (PANAS) and Epworth Sleepiness Scale (ESS) were obtained on a 145 
weekly basis directly before, and after centrifugation. MSAQ was employed to determine 146 
(1 to 9 max) various dimensions (e.g. gastrointestinal) of motion sickness [32]. PANAS 147 
was used to assess the effect of centrifugation upon mood. Participants rated each item 148 
on a Likert scale from 1 “not at all” to 5 “very much”. The ESS (via rating from 0 (non-) to 3 149 
“high chance of dozing” in 8 contexts) was used to evaluate “drowsiness” since it is a 150 
cardinal symptom of motion sickness [33-35]. Furthermore, whenever a centrifuge run 151 
was terminated prematurely, the reason was recorded.  152 
  Statistical analysis. Generalized linear mixed models with auto-regressive error 153 
AR(1) were used to determine if there was an effect of bed rest (time effect) and 154 
intervention (intermittent vs. continuous group). Mean values were reported with standard 155 
deviation. All residual plots were evaluated using Kolmogorov-Smirnov with none 156 
displaying large deviations from normality. All statistical tests were conducted using IBM 157 
SPSS version 21 (IBM Corp., USA) with α < 0.05 indicating statistical significance.  158 
 159 
RESULTS 160 
The average spin rate required to generate +1 Gz at the center of mass was 30.5 161 
± 1.0 rpm with radii within 1729 – 2113 mm at the foot plate. The 16 participants 162 
allocated to the two centrifuge groups comprised 10 men and 6 women (71.6 ± 7.4 kg, 33 163 
± 9.9 yrs, 173 ± 8.8 cm) who experienced 960 centrifuge runs in total.   164 
No serious adverse medical events occurred. However, a total of 10 centrifuge 165 
runs (1%, involving 6 different subjects) had to be terminated prematurely; eight runs in 166 
the continuous group and two runs in the intermittent group (Figure 2). Of the 10 167 
terminated runs, seven runs – five in the continuous group and two in the intermittent 168 
group - had to be terminated due to pre-syncopal signs or symptoms, including significant 169 
drop of blood pressure, reporting of tunnel vision and/or lightheadedness. Only one 170 
centrifuge run in the continuous group had to be stopped due to severe motion sickness 171 
(subsequent MS score of 18/20). Two runs in the continuous group had to be terminated 172 
prematurely due to pain resulting from a recent muscle biopsy procedure performed for a 173 
different experiment within the bed rest campaign.  174 
No clinically significant cardiac dysrhythmias were observed during centrifugation. 175 
During continuous centrifugation, two participants demonstrated frequent isolated 176 
premature ventricular complexes on 14 non-consecutive days between bed rest days 5 177 
and 51. Two participants in the continuous group and one in the intermittent centrifugation 178 
group exhibited occasional premature atrial complexes, but there was no apparent 179 
increase in incidence over time. All subjects were, however, able to resume centrifuge 180 
training on subsequent days after a termination. 181 
Comparisons of the initial cardiovascular reactions after 2 minutes of centrifugation 182 
on bed rest days 1, 30 and 60 revealed significant effects during bed rest for mean heart 183 
rate. Mean heart rates were significantly affected by time for the continuous (F = 14.950, p 184 
< 0.001, dfs = 14.073) but not for the intermittent group during bed rest (F = 1.558, p = 185 
0.242, dfs = 15.281). Thus mean heart rate was numerically higher in the continuous 186 
group on bed rest day 60 but not significant (continuous group: 100.5 ± 18.5 vs. 187 
intermittent group: 86.9 ± 5.9, (t (14) = -1.986, p = 0.67) (Table 1). We observed no 188 
significant differences in systolic and diastolic blood pressure. 189 
Overall MSSQ scores were similar (p = 0.211) prior to bed rest with 3.5 ± 5.4 (MSA 190 
1.9 ± 2.7; MSB 1.6 ± 2.7) for the intermittent centrifugation, 6.0 ± 3.7 (MSA 2.9 ± 2.4; MSB 191 
3.1 ± 2.1) for the continuous centrifugation, and 4.7 ± 4.1 (MSA 2.8 ± 2.8; MSB 1.9 ± 3.0) 192 
for the control group.  193 
Daily motion sickness scores were significantly higher in the continuous 194 
centrifugation group during bed rest (F = 92.8, p = 0.001, dfs = 202.5) with no effect of bed 195 
rest time (F = 0.268, p = 0.605, dfs = 217.2) (Figure 3). Pairwise comparison revealed 196 
higher motion sickness scores in the continuous (3.05 ± 0.11) compared to the intermittent 197 
centrifugation group (1.58 ± 0.11) (p = 0.001).  198 
No significant differences in RPE, MSAQ, PANAS or ESS scores were observed 199 
during the bed rest phase neither in either nor between groups (Figure 4, Table 2). 200 
 201 
DISCUSSION 202 
We evaluated the tolerability of daily artificial gravity via short-arm centrifugation as a 203 
potential countermeasure against deconditioning induced by 60 day bed rest provided 204 
either as a single 30 min run or as 6x5 minute runs. Our main findings were that both 205 
centrifuge interventions were well tolerated (in both males and females), with no serious 206 
adverse events and <1% run termination due to pre-syncopal signs. Only a single run 207 
was stopped due to motion sickness, with two terminated due to pain from an 208 
experimental procedure from another protocol. All subjects were, however, able to 209 
resume centrifuge training on subsequent days. Daily motion sickness scores were low, 210 
but significantly higher in the continuous group across bed rest. MSAQ, PANAS or ESS 211 
scores were low in both centrifugation groups with no difference between groups 212 
indicative of good long-term tolerability.  213 
Short-arm centrifugation induces an orthostatic stress on the cardiovascular 214 
system that markedly differs from standing on Earth. While the body experiences 1 g 215 
terrestrial gravity throughout with standing, the gravitational stimulus increases in a graded 216 
fashion from the head towards the feet during short-arm centrifugation [1].  217 
Yet, previous studies have not observed major differences in cardiovascular 218 
regulation when standing and during short-arm centrifugation [36]. In our study, pre-219 
syncope occurred in only a few runs and we did not observe overt syncope. Pre-syncope 220 
did occur slightly more frequently in the continuous centrifugation group, suggesting that 221 
the breaks in the intermittent protocol may contribute to improved orthostatic tolerance 222 
during centrifugation. However, in both groups the incidence was very low, potentially due 223 
to the fact that subjects were permitted to perform isometric leg muscle pump exercises 224 
when experiencing symptoms. In the absence of countermeasures, bed rest 225 
deconditioning is associated with markedly reduced orthostatic tolerance [37]. 226 
Interestingly, we did not observe worsening tolerability of short-arm centrifugation over 227 
time suggesting that daily artificial gravity may have maintained orthostatic tolerance but 228 
this requires further evaluation including specific testing of orthostatic tolerance during bed 229 
rest [19]. 230 
While we did not observe higher degree cardiac dysrhythmias during centrifugation, 231 
frequent isolated premature ventricular complexes in two participants in the continuous 232 
centrifugation group are noteworthy as long-arm centrifugation nor orthostatic stress 233 
imposed by standing are associated with cardiac dysrhythmias in otherwise healthy 234 
persons [38, 39].  Whether premature ventricular complexes were triggered by short-arm 235 
centrifugation or other stresses resulting from the complex multi-experimental study 236 
cannot be discerned.  It is reassuring that orthostatic stress imposed by standing or long-237 
arm centrifugation rarely produces significant cardiac dysrhythmias in otherwise healthy 238 
persons [38, 39]. While presyncope occurred slightly more frequently in the continuous 239 
centrifugation group the incidence is too small to perform a comprehensive study on 240 
intervention group effects.  Premature termination of a centrifugation runs were also (albeit 241 
rarely) caused by pain due to muscle biopsy from another experiment that were also 242 
associated with higher perceived exertion ratings on bed rest days 6 and 55, corroborated 243 
by subject comments documented by the attending physician.  244 
As the objective of the present study was to expose subjects to +1 Gz at the center 245 
of mass and approximately +2 Gz at the level of the feet, spin rates during centrifugation 246 
were relatively high. During such spin rates head movements can exacerbate motion 247 
sickness due to induced conflicts between acceleration (gravity) perception and other 248 
sensory inputs [25, 40-42]. However, in our study these spin rates were well tolerated 249 
even without physical head restraint or head cover to put subjects into darkness which is 250 
commonly used. Remarkably, despite the fact that participants were requested, but not 251 
physically prevented from moving the head, only a single centrifuge run was stopped due 252 
to severe motion sickness symptoms.  Indeed, daily ratings for motion sickness did not 253 
indicate increases over time in discomfort due to centrifugation-induced cross-coupled 254 
sensations.  255 
Thus, this suggests that by limiting centrifugal acceleration to 5° s-2  the risk of 256 
significant motion sickness is low, even in the intermittent group whom were exposed to 257 
multiple acceleration and decelerations within each session. Thus, why higher (albeit not 258 
high) motion sickness ratings were reported in the continuous group is unknown and 259 
warrants further study – particularly as MSAQ scoring did not differ significantly between 260 
groups. Potential limitations of our study are overestimation of questionnaire results as 261 
direct comparison with the control group were not obtained due to the complexity of the 262 
study. Although  our results may be in accordance with other studies  showing high levels 263 
of vestibular adaption to high speed short radius rotations over time [12, 30, 43] that may 264 
also underlie the low scores for PANAS negative affects – suggesting potentially good 265 
long-term tolerability. 266 
In conclusion short-arm centrifugation was well tolerated (in both males and 267 
females) during 60-days of 6o head-down tilted bedrest. 30 minute intermittent 268 
centrifugation appears to be slightly better tolerated compared to equivalent continuous 269 
centrifugation indicated by lower motion sickness scores and fewer run terminations. 270 
However, the differences were small and require further study in a mixed sex cohort 271 
both as ‘passive’ countermeasures and potentially with concurrent exercise as this may 272 
augment effectiveness against multi-systems de-conditioning.  273 
 274 
  275 
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  418 
FIGURE/TABLE LEGENDS 419 
 420 
Figure 1: Artificial Gravity was generated by centrifugation with +1Gz at Center of Mass 421 
and approx. +2Gz at feet. Participants were randomly assigned to an intermittent 422 
centrifugation group with 6 x 5 min centrifugation with 3 minute breaks (left side) and a 423 
continuous group with 30 min centrifugation (right side). 424 
Figure 2: Premature terminations of centrifuge sessions 425 
 426 
 427 
Figure 3: Mean values with standard error of daily Motion Sickness (MS) rating 428 
immediately following intermittent and continuous centrifugation during 60 day bed rest 429 
in the intermittent and in the continuous centrifugation group. 430 
Figure 4: Mean values with standard error of daily Rating of Perceived Exertion (RPE) 431 
rating immediately following intermittent and continuous centrifugation during 60 day bed 432 
rest in the intermittent and in the continuous centrifugation group. 433 
Table 1: Comparison of mean values for heart rate, systolic and diastolic blood pressure 434 
during the first 2 minutes of centrifugation at the beginning, middle and end of bed rest.  435 
 436 
Table 2: Comparison of tolerability assessment (MSAQ, ESS, PANAS) of both centrifuge 437 
intervention groups at the beginning, middle and end of bed rest.  438 
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  474 
Table 1   475 
 476 
 477 
 Bed rest phase 
 Begin Middle End 
 Intermittent 
group 
Continuous 
group 
Intermittent 
group 
Continuous 
group 
Intermittent 
group 
Continuous 
group 
 
Heart rate 
 
80.3 ± 8.4 
 
 
82.4 ± 14.9 
 
 
86.3 ± 12.7 
 
 
99.13 ± 18.6 
 
 
86.9 ± 5.9 
 
 
100.5 ± 18.5 
 
 
Systolic 
blood 
pressure 
 
119.3 ± 13.4 
 
 
111.9 ± 41 
 
 
122.3 ± 10.4 
 
 
128.8 ± 7.5 
 
 
130.5 ± 13.5  
 
 
132.4 ± 11.1 
 
 
Diastolic 
blood 
pressure 
 
76.6 ± 5.9 
 
80.8 ± 9.5 
 
81.8 ± 4.5 
 
84.3 ± 6.3 
 
88.1 ± 8.2 
 
93.8 ± 11.9 
 478 
  479 
Table 2 480 
 481 
 Bed rest phase 
 Begin Middle End 
 Intermittent 
group 
Continuous 
group 
Intermittent 
group 
Continuous 
group 
Intermittent 
group 
Continuous 
group 
MSAQ       
- Overall  21.96  ± 6.7 20.66  ±  3.7  16.32   ± 2.2 21.76  ± 6.1 19.71  ± 4.4 17.89  ± 2.5 
- Gastrointestinal 21.18  ± 8.9  21.53  ± 4.5 12.50  ± 1.0 22.22  ± 7.6 14.93  ± 3.1 18.06  ± 3.4 
- Central 18.06  ± 6.0 16.95  ± 3.3 13.89  ± 4.1 17.52  ± 5.7 16.11  ± 6.0 14.17  ± 2.5 
- Peripheral  21.30  ± 5.5 25.92  ± 8.2 15.74  ± 0.6 28.39  ± 9.9 20.37  ± 3.7 18.05  ± 1.8 
- Sopite-related 28.12  ± 7.9 20.49  ± 3.9 23.61  ± 4.1 21.61  ± 3.5 28.47  ± 6.4 22.22  ± 3.4 
ESS 12.5  ± 1.3 12.25  ± 1.2 15.25  ± 2.3 12.56  ± 1.4 14.25  ± 2.0 13.36  ± 1.8 
PANAS (Positive 
Affect) 
23.88  ± 2.6 25.75  ± 2.7 24.5  ± 2.0   24.11  ± 2.0 24.50  ± 3.1 22.88  ± 3.2 
PANAS (Negative 
Affect) 
15.50  ± 1.6 13.63  ± 0.5 13.13  ± 0.4 14.44  ± 1.1 15.00  ± 1.2 14.25  ± 0.8 
 482 
 483 
 484 
Supporting informations 485 
 486 
AGBR_Quest_results: List of all results from questionnaires ESS, MSAQ and PANAS in 487 
a comprehensive manner 488 
 489 
Medical data: List of all medical data including heart rate and blood pressure pre and 490 
post centrifugation as well as within first two minutes during centrifugation.  491 
 492 
MS Scoring HDT: Recording of motion sickness questionnaires during 60 days of head 493 
down tilt bed rest. 494 
 495 
RPE Scoring HDT: Recording of perceived exertion questionnaires during 60 days of 496 
head down tilt bed rest. 497 
